Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2003; 42:2000-2006, doi:10.1016/j.jacc.2003.07.021
© 2003 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamamoto, K.
Right arrow Articles by Matsumori, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamamoto, K.
Right arrow Articles by Matsumori, A.

BASIC RESEARCH

Attenuation of virus-induced myocardial injury by inhibition of the angiotensin II type 1 receptor signal and decreased nuclear factor-kappa B activation in knockout mice

Kanjo Yamamoto, MD*, Tetsuo Shioi, MD, PhD*, Koji Uchiyama, MD*, Tadashi Miyamoto, MD, PhD*, Shigetake Sasayama, MD, PhD, FACC* and Akira Matsumori, MD, PhD, FACC*,*

* Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan

Manuscript received June 22, 2003; accepted July 8, 2003.

* Reprint requests and correspondence: Dr. Akira Matsumori, Department of Cardiovascular Medicine, Kyoto University, 54 Kawaracho Shogoin, Sakyo-ku, Kyoto 606-8397, Japan.
amat{at}kuhp.kyoto-u.ac.jp

OBJECTIVES: This study examined the role of angiotensin II (Ang-II) in a murine model of viral myocarditis.

BACKGROUND: Ang-II plays an important role in the pathophysiology of various cardiovascular disorders. However, the role of Ang-II in inflammatory heart diseases is not known.

METHODS: Four-week-old wild-type (WT) and Ang-II type 1 receptor (AT1R) knockout (KO) mice were inoculated with the encephalomyocarditis virus (EMCV). Survival, histopathology, expression of proinflammatory cytokines, and activity of nuclear factor-kappa B (NF-kB) in the heart were examined.

RESULTS: The 14-day survival was significantly increased in KO compared with WT mice. Histopathologic scores for myocardial necrosis (0.86 ± 0.69 vs. 2.44 ± 0.88, p < 0.01) and cellular infiltration (0.86 ± 0.38 vs. 2.33 ± 0.50, p < 0.01) were lower in KO than in WT mice. The expression of tumor necrosis factor-alpha (TNF-alpha) was increased 43.2-fold, that of interleukin-1-beta (IL-1-beta) 45.8-fold, and the activity of NF-kB 2.24-fold by EMCV inoculation in WT mice (each p < 0.01), but not in KO mice (5.9-fold, 6.3-fold, and 1.12-fold, respectively, each p = NS). The AT1R blocker also significantly attenuated the expression of proinflammatory cytokines and the activation of NF-kB in virus-inoculated WT mice. Intravenous Ang-II injection enhanced the activation of NF-kB (2.28-fold, p < 0.01) and increased the expression of TNF-alpha (2.31-fold, p < 0.01) and IL-1-beta (2.45-fold, p < 0.01) in heart tissue of WT but not KO mice.

CONCLUSIONS: These results indicate that the AT1R signal is obligatory for the development of virus-induced myocardial injury through the proinflammatory action of Ang-II via the NF-kB/cytokine pathway.

Abbreviations and Acronyms
  Ang-II = angiotensin II
  AP-1 = activator protein-1
  AT1R = angiotensin II type 1 receptor
  EMCV = encephalomyocarditis virus
  EMSA = electrophoretic mobility shift assay
  HW/BW = heart weight to body weight ratio
  IL-1-beta = interleukin-1-beta
  KO = knockout
  NF-kB = nuclear factor-kappa B
  PBS = phosphate-buffered saline
  PCR = polymerase chain reaction
  TNF-alpha = tumor necrosis factor-alpha
  WT = wild-type




This article has been cited by other articles:


Home page
Eur J Heart FailHome page
J. Xiao, M. Shimada, W. Liu, D. Hu, and A. Matsumori
Anti-inflammatory effects of eplerenone on viral myocarditis
Eur J Heart Fail, April 1, 2009; 11(4): 349 - 353.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
K. J.E. Sattler, J. E. Woodrum, O. Galili, M. Olson, S. Samee, F. B. Meyer, X.-Y. Zhu, L. O. Lerman, and A. Lerman
Concurrent Treatment With Renin-Angiotensin System Blockers and Acetylsalicylic Acid Reduces Nuclear Factor {kappa}B Activation and C-Reactive Protein Expression in Human Carotid Artery Plaques
Stroke, January 1, 2005; 36(1): 14 - 20.
[Abstract] [Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement